title: Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria.
abstract: Twenty percent of the familial form of amyotrophic lateral sclerosis (ALS) is caused by mutations in the Cu, Zn-superoxide dismutase gene (SOD1) through the gain of a toxic function. The nature of this toxic function of mutant SOD1 has remained largely unknown. Here we show that WT SOD1 not only hastens onset of the ALS phenotype but can also convert an unaffected phenotype to an ALS phenotype in mutant SOD1 transgenic mouse models. Further analyses of the single- and double-transgenic mice revealed that conversion of mutant SOD1 from a soluble form to an aggregated and detergent-insoluble form was associated with development of the ALS phenotype in transgenic mice. Conversion of WT SOD1 from a soluble form to an aggregated and insoluble form also correlates with exacerbation of the disease or conversion to a disease phenotype in double-transgenic mice. This conversion, observed in the mitochondrial fraction of the spinal cord, involved formation of insoluble SOD1 dimers and multimers that are crosslinked through intermolecular disulfide bonds via oxidation of cysteine residues in SOD1. Our data thus show a molecular mechanism by which SOD1, an important protein in cellular defense against free radicals, is converted to aggregated and apparently ALS-associated toxic dimers and multimers by redox processes. These findings provide evidence of direct links among oxidation, protein aggregation, mitochondrial damage, and SOD1-mediated ALS, with possible applications to the aging process and other late-onset neurodegenerative disorders. Importantly, rational therapy based on these observations can now be developed and tested.
authors.affiliation: Davee Department of Neurology and Clinical Neurosciences, Northwestern University Feinberg School of Medicine, Tarry Building, Room 13-715, 303 East Chicago Avenue, Chicago, IL 60611, USA. h-deng@northwestern.edu
authors.forename: Han-Xiang
authors.initials: HX
authors.lastname: Deng
authors.forename: Yong
authors.initials: Y
authors.lastname: Shi
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Furukawa
authors.forename: Hong
authors.initials: H
authors.lastname: Zhai
authors.forename: Ronggen
authors.initials: R
authors.lastname: Fu
authors.forename: Erdong
authors.initials: E
authors.lastname: Liu
authors.forename: George H
authors.initials: GH
authors.lastname: Gorrie
authors.forename: Mohammad S
authors.initials: MS
authors.lastname: Khan
authors.forename: Wu-Yen
authors.initials: WY
authors.lastname: Hung
authors.forename: Eileen H
authors.initials: EH
authors.lastname: Bigio
authors.forename: Thomas
authors.initials: T
authors.lastname: Lukas
authors.forename: Mauro C
authors.initials: MC
authors.lastname: Dal Canto
authors.forename: Thomas V
authors.initials: TV
authors.lastname: O'Halloran
authors.forename: Teepu
authors.initials: T
authors.lastname: Siddique
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000201:enzymology* / Q000235:genetics; D000818:Animals; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D008928:Mitochondria / Q000201:enzymology* / Q000648:ultrastructure; D009154:Mutation; D010641:Phenotype; D011487:Protein Conformation; D013116:Spinal Cord / Q000166:cytology; D013482:Superoxide Dismutase / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism*; D000072105:Superoxide Dismutase-1; D015996:Survival Rate
chemical_list: C000606290:SOD1 protein, human; C000606291:Sod1 protein, mouse; D013482:Superoxide Dismutase; D000072105:Superoxide Dismutase-1